Equity ETFs M&A Activity, Passing Drug Trials Help Biotech ETFs Rebound By Max ChenSeptember 12, 2016
Podcasts High Growth Comes With Risk in Biotech ETF Space (Podcast) By Brenton GarenSeptember 9, 2016
Equity ETFs For Biotech ETFs, It’s All About U.S. Presidential Politics By Tom LydonSeptember 1, 2016
Equity ETFs Could Financial Services be Vulnerable to a Clinton Presidency? By Tom LydonAugust 30, 2016
Equity ETFs Clinton Mylan Attack Reminds Biotech ETF Investors of Election Risks By Max ChenAugust 25, 2016
